Stay Up to Date
Breaking News,
Updates, & More
Click Here to
Subscribe

From The Editors

TOP - January 2022 Vol 15, No 1 – Online Only - From the Editors

In the January issue of The Oncology Pharmacist (TOP), we feature the latest news and updates relevant to pharmacy professionals working in the field of oncology. We begin this issue with highlights from the ASH 2021 Annual Meeting and Exposition, where experts presented key data on novel drugs and combination regimens aimed at improving outcomes for patients diagnosed with cancer.

In a noteworthy session during this meeting, L. Elizabeth Budde, MD, PhD, presented encouraging results from a clinical trial evaluating the safety and efficacy of the investigational agent, mosunetuzumab, in patients with relapsed/refractory follicular lymphoma (see here). Dr Budde explained that because this drug is already premade, it may offer advantages over many CAR T-cell therapies.

“Some patients may not have time to wait for CAR T-cell production and, therefore, a mosunetuzumab treatment off-the-shelf, readily available, will be appealing if there are any larger issues,” she said.

We also provide readers with highlights from the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021, where stakeholders gathered to exchange their knowledge, insights, and real-world experience with the common goal of making cancer care more affordable and accessible to patients. In a session on the current and future state of Medically Integrated Pharmacy and the benefits of this approach in oncology, Stacey McCullough, PharmD, said that a new National Community Oncology Dispensing Association Center of Excellence accreditation shows promise (see here).

“It’s going to be collaborative with the practice and the quality and value that it brings. It’s going to be across the board to all stakeholders, making sure that each activity is focused on the outcome of the patient,” she said.

Other key sessions and roundtable discussions during this meeting addressed ongoing efforts to reform oncologic drug pricing (see here), strategies for future-proofing cancer care against pandemics (see here), and the utility of value-based contracting in oncology to improve patient care (see here).

This issue of TOP also includes data from recent clinical trials assessing the efficacy and tolerability of novel and established drugs being used to treat patients with various types of solid tumors, including colorectal, prostate, and lung cancer.

As always, we hope you will enjoy this issue of TOP, and we invite you to visit www.TheOncologyPharmacist.com to share your feedback about this issue with us or send comments to info@TheOncologyPharmacist.com. We look forward to receiving your feedback.

Related Items
From The Editors July 2022
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - July 2022 Vol 15, No 4 published on July 20, 2022 in From the Editors
From The Editors: May 2022
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - May 2022 Vol 15, No 3 published on May 6, 2022 in From the Editors
From The Editors March 2022
TOP - March 2022 Vol 15, No 2 published on March 16, 2022 in From the Editors
From The Editors: November 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - November 2021 Vol 14, No 7 published on November 10, 2021 in From the Editors
From The Editors: October 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - October 2021 Vol 14, No 6 | Biosimilars published on November 5, 2021 in From the Editors, Biosimilars
From The Editors September 2021
Patrick J. Medina, PharmD, BCOP
TOP - September 2021 Vol 14, No 5 published on September 7, 2021 in From the Editors
From The Editors July 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - July 2021 Vol 14, No 4 published on July 20, 2021 in From the Editors
From The Editors May 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - May 2021 Vol 14, No 3 published on May 14, 2021 in From the Editors
From The Editors March 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - March 2021 Vol 14, No 2 published on March 11, 2021 in From the Editors
From The Editors January 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - January 2021 Vol 14, No 1 published on February 9, 2021 in From the Editors
Last modified: February 1, 2022